Circulating Neoplastic-Immune Hybrid Cells Predict Metastatic Progression in Uveal Melanoma.
Michael S ParappillyYuki ChinRiley M WhalenAshley N AndersonTrinity S RobinsonLuke StrgarThomas Lee SuttonPatrick ConleyChristopher KlockeSummer L GibbsYoung Hwan ChangGuanming WuMelissa H WongAlison H SkaletPublished in: Cancers (2022)
CHCs are a novel and promising prognostic biomarker in uveal melanoma.